line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,HCG.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.142732,HCG.NS
Normalized EBITDA,2025-03-31 00:00:00,4228600000.0,HCG.NS
Total Unusual Items,2025-03-31 00:00:00,0.0,HCG.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,0.0,HCG.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,444100000.0,HCG.NS
Reconciled Depreciation,2025-03-31 00:00:00,2113400000.0,HCG.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,10622700000.0,HCG.NS
EBITDA,2025-03-31 00:00:00,4228600000.0,HCG.NS
EBIT,2025-03-31 00:00:00,2115200000.0,HCG.NS
Net Interest Income,2025-03-31 00:00:00,-1545600000.0,HCG.NS
Interest Expense,2025-03-31 00:00:00,1545600000.0,HCG.NS
Interest Income,2025-03-31 00:00:00,,HCG.NS
Normalized Income,2025-03-31 00:00:00,444100000.0,HCG.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,444100000.0,HCG.NS
Total Expenses,2025-03-31 00:00:00,20422000000.0,HCG.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,HCG.NS
Diluted Average Shares,2025-03-31 00:00:00,141433121.0,HCG.NS
Basic Average Shares,2025-03-31 00:00:00,139216301.0,HCG.NS
Diluted EPS,2025-03-31 00:00:00,3.14,HCG.NS
Basic EPS,2025-03-31 00:00:00,3.19,HCG.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,444100000.0,HCG.NS
Net Income Common Stockholders,2025-03-31 00:00:00,444100000.0,HCG.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,HCG.NS
Net Income,2025-03-31 00:00:00,444100000.0,HCG.NS
Minority Interests,2025-03-31 00:00:00,-44200000.0,HCG.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,488300000.0,HCG.NS
Net Income Continuous Operations,2025-03-31 00:00:00,488300000.0,HCG.NS
Tax Provision,2025-03-31 00:00:00,81300000.0,HCG.NS
Pretax Income,2025-03-31 00:00:00,569600000.0,HCG.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,348100000.0,HCG.NS
Special Income Charges,2025-03-31 00:00:00,0.0,HCG.NS
Other Special Charges,2025-03-31 00:00:00,,HCG.NS
Write Off,2025-03-31 00:00:00,,HCG.NS
Restructuring And Mergern Acquisition,2025-03-31 00:00:00,,HCG.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-1545600000.0,HCG.NS
Total Other Finance Cost,2025-03-31 00:00:00,,HCG.NS
Interest Expense Non Operating,2025-03-31 00:00:00,1545600000.0,HCG.NS
Interest Income Non Operating,2025-03-31 00:00:00,,HCG.NS
Operating Income,2025-03-31 00:00:00,1759400000.0,HCG.NS
Operating Expense,2025-03-31 00:00:00,9799300000.0,HCG.NS
Other Operating Expenses,2025-03-31 00:00:00,4198200000.0,HCG.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,2113400000.0,HCG.NS
Amortization,2025-03-31 00:00:00,,HCG.NS
Depreciation Income Statement,2025-03-31 00:00:00,2113400000.0,HCG.NS
Selling General And Administration,2025-03-31 00:00:00,,HCG.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,HCG.NS
General And Administrative Expense,2025-03-31 00:00:00,,HCG.NS
Rent And Landing Fees,2025-03-31 00:00:00,,HCG.NS
Gross Profit,2025-03-31 00:00:00,11558700000.0,HCG.NS
Cost Of Revenue,2025-03-31 00:00:00,10622700000.0,HCG.NS
Total Revenue,2025-03-31 00:00:00,22181400000.0,HCG.NS
Operating Revenue,2025-03-31 00:00:00,22181400000.0,HCG.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,15203780.271707,HCG.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.389841,HCG.NS
Normalized EBITDA,2024-03-31 00:00:00,3469200000.0,HCG.NS
Total Unusual Items,2024-03-31 00:00:00,39000000.0,HCG.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,39000000.0,HCG.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,481400000.0,HCG.NS
Reconciled Depreciation,2024-03-31 00:00:00,1743600000.0,HCG.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,8889900000.0,HCG.NS
EBITDA,2024-03-31 00:00:00,3508200000.0,HCG.NS
EBIT,2024-03-31 00:00:00,1764600000.0,HCG.NS
Net Interest Income,2024-03-31 00:00:00,-1087400000.0,HCG.NS
Interest Expense,2024-03-31 00:00:00,1087400000.0,HCG.NS
Interest Income,2024-03-31 00:00:00,126970000.0,HCG.NS
Normalized Income,2024-03-31 00:00:00,457603780.271707,HCG.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,481400000.0,HCG.NS
Total Expenses,2024-03-31 00:00:00,17526400000.0,HCG.NS
Rent Expense Supplemental,2024-03-31 00:00:00,218400000.0,HCG.NS
Diluted Average Shares,2024-03-31 00:00:00,140349854.0,HCG.NS
Basic Average Shares,2024-03-31 00:00:00,139132948.0,HCG.NS
Diluted EPS,2024-03-31 00:00:00,3.43,HCG.NS
Basic EPS,2024-03-31 00:00:00,3.46,HCG.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,481400000.0,HCG.NS
Net Income Common Stockholders,2024-03-31 00:00:00,481400000.0,HCG.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,HCG.NS
Net Income,2024-03-31 00:00:00,481400000.0,HCG.NS
Minority Interests,2024-03-31 00:00:00,68200000.0,HCG.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,413200000.0,HCG.NS
Net Income Continuous Operations,2024-03-31 00:00:00,413200000.0,HCG.NS
Tax Provision,2024-03-31 00:00:00,264000000.0,HCG.NS
Pretax Income,2024-03-31 00:00:00,677200000.0,HCG.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,169400000.0,HCG.NS
Special Income Charges,2024-03-31 00:00:00,39000000.0,HCG.NS
Other Special Charges,2024-03-31 00:00:00,-38880000.0,HCG.NS
Write Off,2024-03-31 00:00:00,4320000.0,HCG.NS
Restructuring And Mergern Acquisition,2024-03-31 00:00:00,,HCG.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-1087400000.0,HCG.NS
Total Other Finance Cost,2024-03-31 00:00:00,76610000.0,HCG.NS
Interest Expense Non Operating,2024-03-31 00:00:00,1087400000.0,HCG.NS
Interest Income Non Operating,2024-03-31 00:00:00,126970000.0,HCG.NS
Operating Income,2024-03-31 00:00:00,1552300000.0,HCG.NS
Operating Expense,2024-03-31 00:00:00,8636500000.0,HCG.NS
Other Operating Expenses,2024-03-31 00:00:00,3853000000.0,HCG.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,1743600000.0,HCG.NS
Amortization,2024-03-31 00:00:00,77250000.0,HCG.NS
Depreciation Income Statement,2024-03-31 00:00:00,1743600000.0,HCG.NS
Selling General And Administration,2024-03-31 00:00:00,1079950000.0,HCG.NS
Selling And Marketing Expense,2024-03-31 00:00:00,401240000.0,HCG.NS
General And Administrative Expense,2024-03-31 00:00:00,678710000.0,HCG.NS
Rent And Landing Fees,2024-03-31 00:00:00,218400000.0,HCG.NS
Gross Profit,2024-03-31 00:00:00,10188800000.0,HCG.NS
Cost Of Revenue,2024-03-31 00:00:00,8889900000.0,HCG.NS
Total Revenue,2024-03-31 00:00:00,19078700000.0,HCG.NS
Operating Revenue,2024-03-31 00:00:00,19078700000.0,HCG.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,-97836000.0,HCG.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.3,HCG.NS
Normalized EBITDA,2023-03-31 00:00:00,3324380000.0,HCG.NS
Total Unusual Items,2023-03-31 00:00:00,-326120000.0,HCG.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,-326120000.0,HCG.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,293490000.0,HCG.NS
Reconciled Depreciation,2023-03-31 00:00:00,1634730000.0,HCG.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,7997550000.0,HCG.NS
EBITDA,2023-03-31 00:00:00,2998260000.0,HCG.NS
EBIT,2023-03-31 00:00:00,1363530000.0,HCG.NS
Net Interest Income,2023-03-31 00:00:00,-866680000.0,HCG.NS
Interest Expense,2023-03-31 00:00:00,914730000.0,HCG.NS
Interest Income,2023-03-31 00:00:00,118100000.0,HCG.NS
Normalized Income,2023-03-31 00:00:00,521774000.0,HCG.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,293490000.0,HCG.NS
Total Expenses,2023-03-31 00:00:00,15107190000.0,HCG.NS
Rent Expense Supplemental,2023-03-31 00:00:00,111550000.0,HCG.NS
Diluted Average Shares,2023-03-31 00:00:00,139073790.0,HCG.NS
Basic Average Shares,2023-03-31 00:00:00,139073790.0,HCG.NS
Diluted EPS,2023-03-31 00:00:00,2.1,HCG.NS
Basic EPS,2023-03-31 00:00:00,2.11,HCG.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,293490000.0,HCG.NS
Net Income Common Stockholders,2023-03-31 00:00:00,293490000.0,HCG.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,HCG.NS
Net Income,2023-03-31 00:00:00,293490000.0,HCG.NS
Minority Interests,2023-03-31 00:00:00,117190000.0,HCG.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,176300000.0,HCG.NS
Net Income Continuous Operations,2023-03-31 00:00:00,176300000.0,HCG.NS
Tax Provision,2023-03-31 00:00:00,272500000.0,HCG.NS
Pretax Income,2023-03-31 00:00:00,448800000.0,HCG.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,6060000.0,HCG.NS
Special Income Charges,2023-03-31 00:00:00,-326470000.0,HCG.NS
Other Special Charges,2023-03-31 00:00:00,9350000.0,HCG.NS
Write Off,2023-03-31 00:00:00,317120000.0,HCG.NS
Restructuring And Mergern Acquisition,2023-03-31 00:00:00,0.0,HCG.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-866680000.0,HCG.NS
Total Other Finance Cost,2023-03-31 00:00:00,70050000.0,HCG.NS
Interest Expense Non Operating,2023-03-31 00:00:00,914730000.0,HCG.NS
Interest Income Non Operating,2023-03-31 00:00:00,118100000.0,HCG.NS
Operating Income,2023-03-31 00:00:00,1653280000.0,HCG.NS
Operating Expense,2023-03-31 00:00:00,7109640000.0,HCG.NS
Other Operating Expenses,2023-03-31 00:00:00,1785330000.0,HCG.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,1634730000.0,HCG.NS
Amortization,2023-03-31 00:00:00,114450000.0,HCG.NS
Depreciation Income Statement,2023-03-31 00:00:00,1520280000.0,HCG.NS
Selling General And Administration,2023-03-31 00:00:00,1010790000.0,HCG.NS
Selling And Marketing Expense,2023-03-31 00:00:00,336500000.0,HCG.NS
General And Administrative Expense,2023-03-31 00:00:00,674290000.0,HCG.NS
Rent And Landing Fees,2023-03-31 00:00:00,111550000.0,HCG.NS
Gross Profit,2023-03-31 00:00:00,8762920000.0,HCG.NS
Cost Of Revenue,2023-03-31 00:00:00,7997550000.0,HCG.NS
Total Revenue,2023-03-31 00:00:00,16760470000.0,HCG.NS
Operating Revenue,2023-03-31 00:00:00,16760470000.0,HCG.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,282273000.0,HCG.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.3,HCG.NS
Normalized EBITDA,2022-03-31 00:00:00,2358520000.0,HCG.NS
Total Unusual Items,2022-03-31 00:00:00,940910000.0,HCG.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,940910000.0,HCG.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,537330000.0,HCG.NS
Reconciled Depreciation,2022-03-31 00:00:00,1582840000.0,HCG.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,6820730000.0,HCG.NS
EBITDA,2022-03-31 00:00:00,3299430000.0,HCG.NS
EBIT,2022-03-31 00:00:00,1716590000.0,HCG.NS
Net Interest Income,2022-03-31 00:00:00,-828050000.0,HCG.NS
Interest Expense,2022-03-31 00:00:00,838870000.0,HCG.NS
Interest Income,2022-03-31 00:00:00,115610000.0,HCG.NS
Normalized Income,2022-03-31 00:00:00,-121307000.0,HCG.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,537330000.0,HCG.NS
Total Expenses,2022-03-31 00:00:00,13056930000.0,HCG.NS
Rent Expense Supplemental,2022-03-31 00:00:00,92800000.0,HCG.NS
Diluted Average Shares,2022-03-31 00:00:00,135182425.0,HCG.NS
Basic Average Shares,2022-03-31 00:00:00,129707612.0,HCG.NS
Diluted EPS,2022-03-31 00:00:00,3.97,HCG.NS
Basic EPS,2022-03-31 00:00:00,4.14,HCG.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,537330000.0,HCG.NS
Net Income Common Stockholders,2022-03-31 00:00:00,537330000.0,HCG.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,HCG.NS
Net Income,2022-03-31 00:00:00,537330000.0,HCG.NS
Minority Interests,2022-03-31 00:00:00,148080000.0,HCG.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,389250000.0,HCG.NS
Net Income Continuous Operations,2022-03-31 00:00:00,389250000.0,HCG.NS
Tax Provision,2022-03-31 00:00:00,488470000.0,HCG.NS
Pretax Income,2022-03-31 00:00:00,877720000.0,HCG.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,4950000.0,HCG.NS
Special Income Charges,2022-03-31 00:00:00,939670000.0,HCG.NS
Other Special Charges,2022-03-31 00:00:00,-1337890000.0,HCG.NS
Write Off,2022-03-31 00:00:00,472450000.0,HCG.NS
Restructuring And Mergern Acquisition,2022-03-31 00:00:00,-74230000.0,HCG.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-828050000.0,HCG.NS
Total Other Finance Cost,2022-03-31 00:00:00,104790000.0,HCG.NS
Interest Expense Non Operating,2022-03-31 00:00:00,838870000.0,HCG.NS
Interest Income Non Operating,2022-03-31 00:00:00,115610000.0,HCG.NS
Operating Income,2022-03-31 00:00:00,774450000.0,HCG.NS
Operating Expense,2022-03-31 00:00:00,6236200000.0,HCG.NS
Other Operating Expenses,2022-03-31 00:00:00,1765620000.0,HCG.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,1582840000.0,HCG.NS
Amortization,2022-03-31 00:00:00,119500000.0,HCG.NS
Depreciation Income Statement,2022-03-31 00:00:00,1463340000.0,HCG.NS
Selling General And Administration,2022-03-31 00:00:00,604900000.0,HCG.NS
Selling And Marketing Expense,2022-03-31 00:00:00,181060000.0,HCG.NS
General And Administrative Expense,2022-03-31 00:00:00,423840000.0,HCG.NS
Rent And Landing Fees,2022-03-31 00:00:00,92800000.0,HCG.NS
Gross Profit,2022-03-31 00:00:00,7010650000.0,HCG.NS
Cost Of Revenue,2022-03-31 00:00:00,6820730000.0,HCG.NS
Total Revenue,2022-03-31 00:00:00,13831380000.0,HCG.NS
Operating Revenue,2022-03-31 00:00:00,13831380000.0,HCG.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,HCG.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,HCG.NS
Normalized EBITDA,2021-03-31 00:00:00,,HCG.NS
Total Unusual Items,2021-03-31 00:00:00,,HCG.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,HCG.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,HCG.NS
Reconciled Depreciation,2021-03-31 00:00:00,,HCG.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,HCG.NS
EBITDA,2021-03-31 00:00:00,,HCG.NS
EBIT,2021-03-31 00:00:00,,HCG.NS
Net Interest Income,2021-03-31 00:00:00,,HCG.NS
Interest Expense,2021-03-31 00:00:00,,HCG.NS
Interest Income,2021-03-31 00:00:00,156110000.0,HCG.NS
Normalized Income,2021-03-31 00:00:00,,HCG.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,HCG.NS
Total Expenses,2021-03-31 00:00:00,,HCG.NS
Rent Expense Supplemental,2021-03-31 00:00:00,53840000.0,HCG.NS
Diluted Average Shares,2021-03-31 00:00:00,,HCG.NS
Basic Average Shares,2021-03-31 00:00:00,,HCG.NS
Diluted EPS,2021-03-31 00:00:00,,HCG.NS
Basic EPS,2021-03-31 00:00:00,,HCG.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,HCG.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,HCG.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,HCG.NS
Net Income,2021-03-31 00:00:00,,HCG.NS
Minority Interests,2021-03-31 00:00:00,,HCG.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,HCG.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,HCG.NS
Tax Provision,2021-03-31 00:00:00,,HCG.NS
Pretax Income,2021-03-31 00:00:00,,HCG.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,HCG.NS
Special Income Charges,2021-03-31 00:00:00,,HCG.NS
Other Special Charges,2021-03-31 00:00:00,510000.0,HCG.NS
Write Off,2021-03-31 00:00:00,804460000.0,HCG.NS
Restructuring And Mergern Acquisition,2021-03-31 00:00:00,0.0,HCG.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,HCG.NS
Total Other Finance Cost,2021-03-31 00:00:00,62320000.0,HCG.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,HCG.NS
Interest Income Non Operating,2021-03-31 00:00:00,156110000.0,HCG.NS
Operating Income,2021-03-31 00:00:00,,HCG.NS
Operating Expense,2021-03-31 00:00:00,,HCG.NS
Other Operating Expenses,2021-03-31 00:00:00,,HCG.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,HCG.NS
Amortization,2021-03-31 00:00:00,120280000.0,HCG.NS
Depreciation Income Statement,2021-03-31 00:00:00,,HCG.NS
Selling General And Administration,2021-03-31 00:00:00,411990000.0,HCG.NS
Selling And Marketing Expense,2021-03-31 00:00:00,135740000.0,HCG.NS
General And Administrative Expense,2021-03-31 00:00:00,276250000.0,HCG.NS
Rent And Landing Fees,2021-03-31 00:00:00,53840000.0,HCG.NS
Gross Profit,2021-03-31 00:00:00,,HCG.NS
Cost Of Revenue,2021-03-31 00:00:00,,HCG.NS
Total Revenue,2021-03-31 00:00:00,,HCG.NS
Operating Revenue,2021-03-31 00:00:00,,HCG.NS
